alexa Efficacy And Safety Of Ferric Carboxymaltose In The Treatment Of Iron Deficiency Anemia In Women With Benign Gynaecological Disorders
ISSN: 2155-9864

Journal of Blood Disorders & Transfusion
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

7th World Hematologists Congress
May 08-09, 2017 Barcelona, Spain

Garima Chaudhry
Lady Hardinge Medical College, India
Posters & Accepted Abstracts: J Blood Disord Transfus
DOI: 10.4172/2155-9864-C1-023
Abstract
The aim of the trial was to study the efficacy and safety of intravenous ferric carboxymaltose (FCM) in gynaecological patients with iron deficiency anemia (IDA) in terms of time of onset of response, improvement in haematological parameters, qualitative improvement in symptoms and adverse effects. A prospective observational study was conducted in a tertiary hospital for duration of one year. 30 gynaecological patients having IDA with Hb 6-8 g/dl and serum ferritin <15μg/L were given intravenous 1000 mg FCM over two weeks (500 mg X 2 infusions). Changes in haematological variables, improvement in clinical parameters and adverse effects were studied over a period of four weeks. At the end of study, Hb increment of ≥3 g% was seen in more than half of patients. Mean Hb increased to 10.14 g/dl from baseline value of 6.97 g/dl at the end of the study with only two infusions of FCM. MCV normalized in 43.33% of women on day 14 and in 100% of women on day 28. Mean serum ferritin increased from baseline value of 7.88 μg/L to 147.70 μg/L on day 28 reflecting replenishment of iron stores. Significant improvement in clinical parameters like fatigue, dyspnoea, palpitations was observed. Minor side effects like headache, dizziness and thrombophlebitis were observed in 13.33%, 10.00% and 6.67% women respectively. We concluded that intravenous FCM is effective, safe and convenient for treatment of IDA in gynaecological patients.
Biography

Email: [email protected]

image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords